Antonio García‐Escudero

BCL-2, TP53 and BAX protein expression in superficial urothelial bladder carcinoma

Ricardo González‐Cámpora, Guillermo Davalos-Casanova, Antonio Beato-Moreno et al. · Cancer Letters · 2006 · 52 citations

Tumor Biology, Urological Research, Urology +6

Cutaneous pseudolymphoma in association with molluscum contagiosum in an elderly patient

D. Moreno‐Ramírez, Antonio García‐Escudero, J.J. Ríos-Martín et al. · Journal of Cutaneous Pathology · 2003 · 48 citations

Granular Cell Atypical Fibroxanthoma: Report of Two Cases

J.J. Ríos-Martín, Mario Díaz Delgado, D. Moreno‐Ramírez et al. · American Journal of Dermatopathology · 2007 · 44 citations

Fibrosis, Atypical Fibroxanthoma, Surgical Pathology +8

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

Concepción de la Piedra, Antonio Alcaraz, Joaquim Bellmunt et al. · British Journal of Cancer · 2013 · 34 citations · Full text

Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?

María José Ríos-Moreno, Sara Jaramillo, S. Pereira Gallardo et al. · Pathology - Research and Practice · 2011 · 31 citations

Several Markers, Prognostic Biomarkers, Pkcθ Expression +11